PIVET rFSH dosing algorithms for individualized controlled ovarian stimulation enables optimized pregnancy productivity rates and avoidance of ovarian hyperstimulation syndrome

John L Yovich1 PIVET Medical Centre, Perth;2 School of Biomedical Science, Curtin Health Innovation Research Institute Bioscience, Curtin University, Perth, WA, AustraliaCorrespondence[email protected]

Birgit Alsbjerg3 The Fertility Clinic, Skive Regional Hospital, Skive;4 Faculty of Health, Aarhus University, Aarhus, Denmark

Jason L Conceicao1 PIVET Medical Centre, Perth

Peter M Hinchliffe1 PIVET Medical Centre, Perth

Kevin N Keane1 PIVET Medical Centre, Perth;2 School of Biomedical Science, Curtin Health Innovation Research Institute Bioscience, Curtin University, Perth, WA, Australia

Pages 2561-2573 | Published online: 10 Aug 2016

Cite this article
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

References

Popovic-TodorovicBLoftABredkjæerHEBangsbøllSNielsenIKAndersenANA prospective randomized clinical trial comparing an individual dose of recombinant FSH based on predictive factors versus a ‘standard’ dose of 150 IU/day in ‘standard’ patients undergoing IVF/ICSI treatmentHuman Reprod2003181122752282
PubMed Web of Science ®Google Scholar
Popovic-TodorovicBLoftALindhardABangsbøllSAnderssonAMAndersenANA prospective study of predictive factors of ovarian response in ‘standard’ IVF/ICSI patients treated with recombinant FSH. A suggestion for a recombinant FSH dosage normogramHuman Reprod2003184781787
PubMed Web of Science ®Google Scholar
HowlesCMSaundersHAlamVEngrandPPredictive factors and a corresponding treatment algorithm for controlled ovarian stimulation in patients treated with recombinant human follicle stimulating hormone (Follitropin alfa) during assisted reproduction technology (ART) procedures. An analysis of 1378 patientsCurr Med Res Opin200622590791816709312
PubMed Web of Science ®Google Scholar
OlivennesFHowlesCMBoriniAIndividualizing FSH dose for assisted reproduction using a novel algorithm: the CONSORT studyReprod Biomed Online200918219520419192339
PubMed Web of Science ®Google Scholar
YovichJStangerJHinchliffePTargeted gonadotrophin stimulation using the PIVET algorithm markedly reduces the risk of OHSSReprod Biomed Online201224328129222296972
PubMed Web of Science ®Google Scholar
StangerJDYovichJLFollicle recruitment determines IVF productivity rate via the number of embryos frozen and subsequent transfersReprod Biomed Online201327328629623886680
PubMed Web of Science ®Google Scholar
BodriDKawachiyaSBruckerMDCumulative success rates following mild IVF in unselected infertile patients: a 3-year, single-centre cohort studyReprod Biomed Online201428557258124631167
PubMed Web of Science ®Google Scholar
NelsonSMIliodromitiSFlemingRAndersonRMcConnachieAMessowC-MReference range for the antimüllerian hormone Generation II assay: a population study of 10,984 women, with comparison to the established Diagnostics Systems Laboratory nomogramFertil Steril20141012523529.e52124220704
PubMed Web of Science ®Google Scholar
HumaidanPEjdrup BredkjærHBungumLGnRH agonist (buserelin) or hCG for ovulation induction in GnRH antagonist IVF/ICSI cycles: a prospective randomized studyHuman Reprod200520512131220
PubMed Web of Science ®Google Scholar
FischJDKeskintepeLSherGGonadotropin-releasing hormone agonist/antagonist conversion with estrogen priming in low responders with prior in vitro fertilization failureFertil Steril200889234234717562336
PubMed Web of Science ®Google Scholar
NelsonSMBiomarkers of ovarian response: current and future applicationsFertil Steril201399496396923312225
PubMed Web of Science ®Google Scholar
YovichJLEdirisingheWRCumminsJMEvaluation of luteal support therapy in a randomized controlled study within a GIFT programFertil Steril19915511311391986952
PubMed Web of Science ®Google Scholar
YovichJLTreatments to enhance implantationChapmanMGrudzinskasJGChardTImplantation: Biological and Clinical AspectsLondonSpringer-Verlag1989239254
Google Scholar
YovichJLStangerJDKeaneKNCumulative live birth rate: an outmoded termJFIV Reprod Med Genet20164165
Google Scholar
MacaldowieAWandYAChughtaiAAChambersGMAssisted Reproductive Technologies in Australia and New Zealand 2012SydneyNational Perinatal Epidemiology and Statistics Unit, the University of New South Wales2014
Google Scholar
FiorentinoFBonoSBiricikAApplication of next-generation sequencing technology for comprehensive aneuploidy screening of blastocysts in clinical preimplantation genetic screening cyclesHuman Reprod2014291228022813
PubMed Web of Science ®Google Scholar
YovichJLConceicaoJHinchliffePKeaneKWhich blastocysts should be considered for genetic screening?Human Reprod201530717431744
PubMed Web of Science ®Google Scholar
JiJLiuYTongXHLuoLMaJChenZThe optimum number of oocytes in IVF treatment: an analysis of 2455 cycles in ChinaHuman Reprod2013281027282734
PubMed Web of Science ®Google Scholar
SunkaraSKRittenbergVRaine-FenningNBhattacharyaSZamoraJCoomarasamyAAssociation between the number of eggs and live birth in IVF treatment: an analysis of 400 135 treatment cyclesHuman Reprod201126717681774
PubMed Web of Science ®Google Scholar
ChenY-hXuX-hWangQOptimum oocyte retrieved and transfer strategy in young women with normal ovarian reserve undergoing a long treatment protocol: a retrospective cohort studyJ Assist Reprod Genet201532101459146726384107
PubMed Web of Science ®Google Scholar
HumaidanPKolSPapanikolaouEGnRH agonist for triggering of final oocyte maturation: time for a change of practice?Human Reprod Update2011174510524
PubMed Web of Science ®Google Scholar
DevroeyPPolyzosNPBlockeelCAn OHSS-free clinic by segmentation of IVF treatmentHuman Reprod2011261025932597
PubMed Web of Science ®Google Scholar
YovichJLStangerJDYovichJMTuvikAIHormonal profiles in the follicular phase, luteal phase and first trimester of pregnancies arising from in-vitro fertilizationBr J Obstet Gynaecol19859223743842580551
PubMedGoogle Scholar
YovichJLConceicaoJLStangerJDHinchliffePMKeaneKNMid-luteal serum progesterone concentrations govern implantation rates for cryopreserved embryo transfers conducted under hormone replacementReprod Biomed Online201531218019126099447
PubMed Web of Science ®Google Scholar

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

PIVET rFSH dosing algorithms for individualized controlled ovarian stimulation enables optimized pregnancy productivity rates and avoidance of ovarian hyperstimulation syndrome

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

PIVET rFSH dosing algorithms for individualized controlled ovarian stimulation enables optimized pregnancy productivity rates and avoidance of ovarian hyperstimulation syndrome

References

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date